Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.

Alzheimer's disease (AD) is a protein misfolding disease characterized by a buildup of β-amyloid (Aβ) peptide as senile plaques, uncontrolled neurodegeneration, and memory loss. AD pathology is linked to the destabilization of cellular ionic homeostasis and involves Aβ peptide-plasma membrane interactions. In principle, there are two possible ways through which disturbance of the ionic homeostasis can take place: directly, where the Aβ peptide either inserts into the membrane and creates ion-conductive pores or destabilizes the membrane organization, or, indirectly, where the Aβ peptide interacts with existing cell membrane receptors. To distinguish between these two possible types of Aβ-membrane interactions, we took advantage of the biochemical tenet that ligand-receptor interactions are stereospecific; L-amino acid peptides, but not their D-counterparts, bind to cell membrane receptors. However, with respect to the ion channel-mediated mechanism, like L-amino acids, D-amino acid peptides will also form ion channel-like structures. Using atomic force microscopy (AFM), we imaged the structures of both D- and L-enantiomers of the full length Aβ(1-42) when reconstituted in lipid bilayers. AFM imaging shows that both L- and D-Aβ isomers form similar channel-like structures. Molecular dynamics (MD) simulations support the AFM imaged 3D structures. Previously, we have shown that D-Aβ(1-42) channels conduct ions similarly to their L- counterparts. Taken together, our results support the direct mechanism of Aβ ion channel-mediated destabilization of ionic homeostasis rather than the indirect mechanism through Aβ interaction with membrane receptors.

[1]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[2]  Ruth Nussinov,et al.  β-Barrel topology of Alzheimer's β-amyloid ion channels. , 2010, Journal of molecular biology.

[3]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[4]  R. Nussinov,et al.  Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels. , 2009, Biophysical journal.

[5]  I. Parker,et al.  Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.

[6]  E. Giralt,et al.  Fine structure study of Aβ1–42 fibrillogenesis with atomic force microscopy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  G. Schulz The structure of bacterial outer membrane proteins. , 2002, Biochimica et biophysica acta.

[8]  R. Nussinov,et al.  Polymorphism of amyloid β peptide in different environments: implications for membrane insertion and pore formation. , 2011, Soft matter.

[9]  R. Nussinov,et al.  Structural Convergence Among Diverse, Toxic β-Sheet Ion Channels , 2010, The journal of physical chemistry. B.

[10]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  D. Holtzman,et al.  In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation , 1999 .

[12]  Effect of membrane mimicking environment on the conformation of a pore-forming (xSxG)6 peptide. , 2006, Biopolymers.

[13]  A. Mazur,et al.  Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro Aging* , 2006, Journal of Biological Chemistry.

[14]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[15]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[16]  Alexander D. MacKerell,et al.  An ab initio study on the torsional surface of alkanes and its effect on molecular simulations of alkanes and a DPPC bilayer. , 2005, The journal of physical chemistry. B.

[17]  Annalisa Pastore,et al.  From Alzheimer to Huntington: why is a structural understanding so difficult? , 2003, The EMBO journal.

[18]  Ruth Nussinov,et al.  Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. , 2011, Biophysical journal.

[19]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[20]  C. Cotman,et al.  All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids* , 1997, The Journal of Biological Chemistry.

[21]  B. Wallace,et al.  The pore dimensions of gramicidin A. , 1993, Biophysical journal.

[22]  R. Nussinov,et al.  New structures help the modeling of toxic amyloidbeta ion channels. , 2008, Trends in biochemical sciences.

[23]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[24]  R. Lal,et al.  Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel* , 1998, The Journal of Biological Chemistry.

[25]  E. Rojas,et al.  Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Rojas,et al.  A New Hypothesis for the Mechanism of Amyloid Toxicity, Based on the Calcium Channel Activity of Amyloid β Protein (AβP) in Phospholipid Bilayer Membranes , 1993 .

[27]  Ruth Nussinov,et al.  Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome , 2010, Proceedings of the National Academy of Sciences.

[28]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[29]  Rushana Azimova,et al.  Amyloid Peptide Channels , 2004, The Journal of Membrane Biology.

[30]  C. Dobson Protein folding and misfolding , 2003, Nature.

[31]  Bernard R. Brooks,et al.  Solvent-Induced Forces between Two Hydrophilic Groups , 1994 .

[32]  R. Lal,et al.  Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity , 2000 .

[33]  D. Marsh,et al.  Infrared dichroism from the X-ray structure of bacteriorhodopsin. , 2001, Biophysical journal.

[34]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[35]  Ruth Nussinov,et al.  Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. , 2007, Biophysical journal.

[36]  D. Selkoe Folding proteins in fatal ways , 2003, Nature.

[37]  B. Penke,et al.  Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. , 2004, Current protein & peptide science.

[38]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[39]  C. Ionescu-Zanetti,et al.  Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Chew,et al.  Amyloid β peptides aggregation in a mixed membrane bilayer: a molecular dynamics study. , 2011, The journal of physical chemistry. B.

[41]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Kagan,et al.  Amyloid peptide pores and the beta sheet conformation. , 2010, Advances in experimental medicine and biology.

[44]  O. Antzutkin Amyloidosis of Alzheimer's Aβ peptides: solid‐state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies , 2004, Magnetic resonance in chemistry : MRC.

[45]  B. Penke,et al.  Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease , 2004 .

[46]  A. Gliozzi,et al.  Detection of populations of amyloid-like protofibrils with different physical properties. , 2010, Biophysical journal.

[47]  H. Guy,et al.  Models of membrane‐bound Alzheimer's Abeta peptide assemblies , 2010, Proteins.

[48]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[49]  G. Plant,et al.  Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.

[50]  C. Masters,et al.  Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity , 2011, Neurobiology of Aging.

[51]  Alexander D. MacKerell,et al.  Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..

[52]  R. Nussinov,et al.  Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.